|GRANTWAY
EN

Anesthetics for Battlefield Care (ABC)

DARPA - Biological Technologies Office

Share
Favorite
Feedback
Summary
-
21 August 2023
-
-
-
-
-
Research, Development and Innovation
Overview

Anesthetics are remarkable drugs that have long-enabled surgical interventions, but their inherent lack of safety necessitates careful monitoring nearly exclusively within an operating room environment. The Anesthetics for Battlefield Care (ABC) program will test the hypothesis that therapeutic effects of anesthetics can be uncoupled/separated from deleterious effects. ABC endeavors to produce drugs for use in traumatic injury capable of safe, unmonitored anesthesia to enable earlier life-saving interventions, reduce the trauma associated with battlefield-injury, and thereby improve combat casualty outcomes.

Eligibility

All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA. See the Eligibility Information section of the BAA for more information.

Learn more or apply
All information about this funding has been collected from and belongs to the funding organization
12 June 2023